FDA readies new vax safety site

The FDA has posted a new Web site that spells out the safety information that has been gleaned from recently launched vaccines and biologics. The agency is using the site to share what safety information it has gathered on a drug 18 months after its approval or after 10,000 people have used it, whichever comes first. The agency plans to scan a broad base of data on adverse events. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.